| Style | Citing Format |
|---|---|
| MLA | Talebi A, Kargar M. "Hepatoprotective Effects of Metformin in Hepatitis C Virus-Infected Adolescents With Beta Thalassaemia Major." International Journal of Clinical Practice, vol. 75, no. 12, 2021, pp. -. |
| APA | Talebi A, Kargar M (2021). Hepatoprotective Effects of Metformin in Hepatitis C Virus-Infected Adolescents With Beta Thalassaemia Major. International Journal of Clinical Practice, 75(12), -. |
| Chicago | Talebi A, Kargar M. "Hepatoprotective Effects of Metformin in Hepatitis C Virus-Infected Adolescents With Beta Thalassaemia Major." International Journal of Clinical Practice 75, no. 12 (2021): -. |
| Harvard | Talebi A, Kargar M (2021) 'Hepatoprotective Effects of Metformin in Hepatitis C Virus-Infected Adolescents With Beta Thalassaemia Major', International Journal of Clinical Practice, 75(12), pp. -. |
| Vancouver | Talebi A, Kargar M. Hepatoprotective Effects of Metformin in Hepatitis C Virus-Infected Adolescents With Beta Thalassaemia Major. International Journal of Clinical Practice. 2021;75(12):-. |
| BibTex | @article{ author = {Talebi A and Kargar M}, title = {Hepatoprotective Effects of Metformin in Hepatitis C Virus-Infected Adolescents With Beta Thalassaemia Major}, journal = {International Journal of Clinical Practice}, volume = {75}, number = {12}, pages = {-}, year = {2021} } |
| RIS | TY - JOUR AU - Talebi A AU - Kargar M TI - Hepatoprotective Effects of Metformin in Hepatitis C Virus-Infected Adolescents With Beta Thalassaemia Major JO - International Journal of Clinical Practice VL - 75 IS - 12 SP - EP - PY - 2021 ER - |